Pipeline Progress: Clinical trial results for ABVC BioPharma's drug candidates significantly influence investor confidence and stock value. Positive data generally boosts the price, while negative or inconclusive results can lead to declines.

Regulatory Approvals: Decisions by regulatory bodies such as the FDA regarding ABVC's products heavily impact the stock. Approvals increase the commercial viability of their drugs, driving the price up, while rejections have the opposite effect.

Market Sentiment: Overall market conditions and investor sentiment towards biotech companies influence ABVC's stock. Positive economic trends and bullish attitudes towards biotech can lift the stock, while downturns and bearish sentiment can depress it.

Financial Performance: ABVC's cash position, revenues, and expenses play a role. Strong financials can provide investors with confidence, which tends to boost the stock price. Concerns about its financial sustainability can have a negative effect.

Competition: The competitive landscape in the pharmaceutical industry affects ABVC. The emergence of competing drugs or treatments can pressure the stock price. ABVC’s ability to differentiate its products is important.

Partnerships/Collaborations: Agreements with larger pharmaceutical companies or research institutions can validate ABVC's technology and products, leading to price increases. Failure to secure or maintain such partnerships can have a negative effect.

News and Events: Company-specific news, industry reports, and major healthcare events can cause fluctuations in ABVC's stock price. Positive announcements tend to raise prices, whereas negative news tends to lower prices.